ADAM10 plasma levels predict worsening in cognition of older adults: a 3-year follow-up study

ADAM10 plasma levels predict worsening in cognition of older adults: a 3-year follow-up study

Abstract Background Blood-based biomarkers for Alzheimer’s disease (AD) are highly needed in clinic practice. So far, the gold standards for AD diagnosis are brain neuroimaging and beta-amyloid peptide, total tau, and phosphorylated tau in cerebrospinal fluid (CSF); however, they are not attractive...

Full description

Bibliographic Details
Main Authors: Maria Patrícia A. Oliveira Monteiro, Danielle S. M. Salheb Oliveira, Patrícia R. Manzine, Carla M. Crispim Nascimento, Ariene A. dos Santos Orlandi, Grace A. de Oliveira Gomes, Fabiana dos Santos Orlandi, Marisa S. Zazzetta, Henrique Pott-Junior, Marcia R. Cominetti
Format: Article
Language:English
Published: BMC 2021-01-01
Series:Alzheimer’s Research & Therapy
Subjects:
Alzheimer’s disease
ADAM10
Biomarker
Blood
Cognition
Dementia
Online Access:https://doi.org/10.1186/s13195-020-00750-y

Internet

https://doi.org/10.1186/s13195-020-00750-y

Similar Items